These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 20222671)
1. Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer. Brahemi G; Kona FR; Fiasella A; Buac D; Soukupová J; Brancale A; Burger AM; Westwell AD J Med Chem; 2010 Apr; 53(7):2757-65. PubMed ID: 20222671 [TBL] [Abstract][Full Text] [Related]
2. A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Burger AM; Gao Y; Amemiya Y; Kahn HJ; Kitching R; Yang Y; Sun P; Narod SA; Hanna WM; Seth AK Cancer Res; 2005 Nov; 65(22):10401-12. PubMed ID: 16288031 [TBL] [Abstract][Full Text] [Related]
3. Autoubiquitination of BCA2 RING E3 ligase regulates its own stability and affects cell migration. Amemiya Y; Azmi P; Seth A Mol Cancer Res; 2008 Sep; 6(9):1385-96. PubMed ID: 18819927 [TBL] [Abstract][Full Text] [Related]
4. Regulation of metformin response by breast cancer associated gene 2. Buac D; Kona FR; Seth AK; Dou QP Neoplasia; 2013 Dec; 15(12):1379-90. PubMed ID: 24403860 [TBL] [Abstract][Full Text] [Related]
5. RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation. Wang Z; Nie Z; Chen W; Zhou Z; Kong Q; Seth AK; Liu R; Chen C Neoplasia; 2013 Sep; 15(9):1028-35. PubMed ID: 24027428 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation of breast cancer-associated gene 2 by estrogen receptor. Kona FR; Stark K; Bisoski L; Buac D; Cui Q; Dou QP Breast Cancer Res Treat; 2012 Sep; 135(2):495-503. PubMed ID: 22850893 [TBL] [Abstract][Full Text] [Related]
7. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines. Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732 [TBL] [Abstract][Full Text] [Related]
8. Effects of partner proteins on BCA2 RING ligase activity. Bacopulos S; Amemiya Y; Yang W; Zubovits J; Burger A; Yaffe M; Seth AK BMC Cancer; 2012 Feb; 12():63. PubMed ID: 22315970 [TBL] [Abstract][Full Text] [Related]
9. Autoubiquitination of feline E3 ubiquitin ligase BCA2. Wang W; Qu M; Wang J; Zhang X; Zhang H; Wu J; Yu B; Wu H; Kong W; Yu X Gene; 2018 Jan; 638():1-6. PubMed ID: 28964893 [TBL] [Abstract][Full Text] [Related]
10. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines. Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721 [TBL] [Abstract][Full Text] [Related]
11. E3 ubiquitin ligase BCA2 promotes breast cancer stemness by up-regulation of SOX9 by LPS. Zheng M; Liu W; Zhang R; Jiang D; Shi Y; Wu Y; Ge F; Chen C Int J Biol Sci; 2024; 20(7):2686-2697. PubMed ID: 38725852 [TBL] [Abstract][Full Text] [Related]
12. A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cells. Wang F; Zhai S; Liu X; Li L; Wu S; Dou QP; Yan B Cancer Lett; 2011 Jan; 300(1):87-95. PubMed ID: 21035945 [TBL] [Abstract][Full Text] [Related]
13. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells. Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995 [TBL] [Abstract][Full Text] [Related]
14. Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential. Wu K; Huynh KQ; Lu I; Moustakim M; Miao H; Yu C; Haeusgen MJ; Hopkins BD; Huang L; Zheng N; Sanchez R; DeVita RJ; Pan ZQ Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33602808 [TBL] [Abstract][Full Text] [Related]
15. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells. Walter G; Liebl R; von Angerer E J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451 [TBL] [Abstract][Full Text] [Related]
17. Discovery of diethyl 2,5-diaminothiophene-3,4-dicarboxylate derivatives as potent anticancer and antimicrobial agents and screening of anti-diabetic activity: synthesis and in vitro biological evaluation. Part 1. Bozorov K; Ma HR; Zhao JY; Zhao HQ; Chen H; Bobakulov K; Xin XL; Elmuradov B; Shakhidoyatov K; Aisa HA Eur J Med Chem; 2014 Sep; 84():739-45. PubMed ID: 25064350 [TBL] [Abstract][Full Text] [Related]
18. Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer. Burger AM; Kona F; Amemiya Y; Gao Y; Bacopulos S; Seth AK Open Cancer J; 2010; 3(1):116-123. PubMed ID: 21179390 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells. Croker AK; Allan AL Breast Cancer Res Treat; 2012 May; 133(1):75-87. PubMed ID: 21818590 [TBL] [Abstract][Full Text] [Related]